Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516710 | SCV000614629 | uncertain significance | not specified | 2017-07-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000816472 | SCV000956982 | uncertain significance | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2023-08-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PLEC protein function. ClinVar contains an entry for this variant (Variation ID: 448066). This variant has not been reported in the literature in individuals affected with PLEC-related conditions. This variant is present in population databases (rs782377096, gnomAD 0.04%). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 1351 of the PLEC protein (p.Ser1351Arg). |